OTCMKTS:CORBF Global Cord Blood (CORBF) Stock Price, News & Analysis $0.95 0.00 (-0.11%) As of 07/27/2026 09:30 AM Eastern Add Compare Share Share Stock Analysis Stock AnalysisChartSEC FilingsShort InterestBuy This Stock About Global Cord Blood Stock (OTCMKTS:CORBF) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get Global Cord Blood alerts:Sign Up Key Stats Today's Range$0.95▼$0.9550-Day Range$0.95▼$1.0052-Week Range$0.20▼$1.75Volume458 shsAverage Volume10,830 shsMarket Capitalization$115.47 millionP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company Overview Global Cord Blood Corporation, traded on the New York Stock Exchange under the symbol CORBF, is a specialized provider of umbilical cord blood banking services. The company focuses on the collection, processing and long-term cryogenic storage of cord blood stem cells, which can be used for a variety of therapeutic and research applications. Its offerings include private family banking solutions as well as public and directed donation programs designed to support patients in need of hematopoietic stem cell transplants. Headquartered in Hong Kong with principal operations in Japan, Global Cord Blood serves hospitals, obstetric clinics and research institutions across the Asia-Pacific region. The company operates state-of-the-art processing laboratories and storage facilities that comply with international quality and safety standards. In addition to its core preservation services, Global Cord Blood works closely with clinical and academic partners to facilitate clinical trials, regenerative medicine research and the development of novel cell-based therapies. Founded in the early 2000s, Global Cord Blood has built a substantial repository of cord blood units, supporting both patient transplantation needs and ongoing scientific studies. The company’s management team comprises professionals with extensive backgrounds in healthcare, biotechnology and regulatory affairs, ensuring that its operations adhere to best practices in stem cell handling and biobanking. Through strategic collaborations and continuous investment in infrastructure, Global Cord Blood aims to advance the field of cellular therapies and expand access to life-saving stem cell treatments. AI Generated. May Contain Errors. Read More Receive CORBF Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Global Cord Blood and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. CORBF Stock News HeadlinesGlobal Cord Blood Corp.May 25, 2026 | barrons.comGlobal Cord Blood Faces Filing DelaysAugust 15, 2025 | msn.comI’ve been warning my followers for 15 years to NOT do this …Uber fell 40% within six months of going public. Meta dropped 50% in just three months. Robinhood sank 85% in five months. Even SpaceX lost over a trillion dollars in market value in two weeks. History shows most IPOs stumble hard after their debut, including some of the most hyped names in the market. With Anthropic's IPO approaching, one analyst has identified a way to get exposure before the public offering.July 28 at 1:00 AM | Weiss Ratings (Ad)CORBF Global Cord Blood Corporation - Seeking AlphaJuly 3, 2025 | seekingalpha.comGlobal Cord Blood Stock Price History - Investing.comJuly 1, 2025 | investing.comAdia Med Explores International Expansion Following Global Interest in Its Innovative Umbilical Cord Blood Stem Cell TherapiesMarch 25, 2025 | finance.yahoo.comGlobal Cord Blood’s Liquidation and Court Approval UpdatesDecember 5, 2024 | markets.businessinsider.com10 Worst Performing Blue Chip Stocks in 2024October 22, 2024 | insidermonkey.comSee More Headlines CORBF Stock Analysis - Frequently Asked Questions How have CORBF shares performed this year? Global Cord Blood's stock was trading at $0.95 on January 1st, 2026. Since then, CORBF shares have increased by 0.0% and is now trading at $0.95. How do I buy shares of Global Cord Blood? Shares of CORBF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Company Calendar Today7/28/2026Fiscal Year End3/31/2027Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeOTCMKTS SectorMedical Industry Miscellaneous health & allied services, not elsewhere classified Sub-IndustryHealthcare Current SymbolOTCMKTS:CORBF Previous SymbolNYSE:CORBF CIK1467808 Webwww.globalcordbloodcorp.com Phone852-3605-8180Fax852-3605-8181Employees1,200Year Founded2003Profitability EPS (Trailing Twelve Months)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding Shares121,550,000Free Float120,943,000Market Cap$115.47 million OptionableNot Optionable Beta-0.77 Social Links Options Trading Made Easy - Download NowLearn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.Get This Free Report This page (OTCMKTS:CORBF) was last updated on 7/28/2026 by MarketBeat.com Staff. From Our PartnersNevada gold explorer near Kinross district draws attentionGold has surged past $5,300 per ounce, with Goldman Sachs and JPMorgan forecasting $6,000+ by end of 2026. Cen...Wall Street Logic | SponsoredMy top 3 AI picks for the next decadeAlexander Green bought Apple in 1996, recommended Nvidia at a split-adjusted 66 cents in 2004, and picked up A...The Oxford Club | SponsoredHow the JPMorgan $8,000 Gold Call Exposed the Biggest Mistake in Most Retirement AccountsJPMorgan has raised its 2026 gold forecast to $6,300, with a credible path to $8,000, and now calls gold a cor...Golden Crest Metals | SponsoredA 50-year dollar arrangement just ended - what it means for youIn 1974, Henry Kissinger helped create the U.S.-Saudi Arabia Joint Commission on Economic Cooperation - a litt...Golden Portfolio | SponsoredSpaceX pays a 10X launch penaltySpaceX burns roughly $200,000 in fuel per Falcon 9 launch - about $20 million across 100 missions. One unde...Freedom Financial | Sponsored60 years. Zero competitors.One company has spent 60 years developing an energy source the International Energy Agency estimates at 140 ti...Behind the Markets | SponsoredWhat Elon told his top shareholders in TexasLate last year, Elon Musk gathered top shareholders at Tesla's Texas Gigafactory to unveil a plan to double Am...Banyan Hill Publishing | SponsoredBofA: Digital Dollar Coming 2025-2030A little-known meeting in 1910 cost the average American family their entire financial freedom. They met in se...Decentralized Masters | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Global Cord Blood Co. Please log in to your account or sign up in order to add this asset to your watchlist. Share Global Cord Blood With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
